The New York Times takes a look at the growing number of sophisticated genetic diagnostic tests that are now available. On the bright side, these tests are seen as guideposts to a future for personalized medicine, where such tests will match patients with the drugs best suited to treat their condition. On the not-so-sunny side is the projection that these expensive tests will further divide patients who have the money to pay for them from the rest of the people who find they are not covered by their insurance policies.
- here's the article from The New York Times